Skip to content

Comparison of Bronchoalveolar Lavage, Mini-Bronchoalveolar Lavage and Endotracheal Aspirate

The Feasibility and Diagnostic Potential Of Novel Material In Mini Bronchoalveolar Lavage and Comparison With Traditional Bronchoalveolar Lavage and Endotracheal Aspirate ( ETA )

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080092
Enrollment
43
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders Health Condition 2: J22- Unspecified acute lower respiratory infection

Interventions

Intervention1: Mini Bronchoalveolar Lavage: The initial design of Mini Bronchoalveolar lavage was done using solid work program and subsequently processed using silicone into two tubes and former into

Sponsors

Saveetha Medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Ability to give consent 2.Patient who are on ventilator 3.Patients with suspected lung infections (e.g., pneumonia) 4.Patients with suspected interstitial lung diseases (e.g., sarcoidosis, idiopathic 5.pulmonary fibrosis) for diagnostic evaluation. 6.Immunocompromised patients with suspected opportunistic infections (e.g., 7.Pneumocystis jirovecii pneumonia) or lung complications. 8.Patients with suspected aspiration syndromes 9.Evaluation of diffuse alveolar hemorrhage in patients with known vasculitis 10.Investigation of occupational lung diseases (e.g., pneumoconiosis

Exclusion criteria

Exclusion criteria: 1.Age above 80 years or age less than 18 years 2.Patient who are unable to give consent 3.Patients who are hemodynamically unstable 4.Patients with uncontrolled bleeding disorders or on anticoagulant therapy where the risk of bleeding outweighs the benefits of the procedure. 4.Patients with severe hypoxemia that may not tolerate the procedure well. 5.Patients with significant facial or upper airway trauma or obstruction that impedes safe passage of the bronchoscope. 6.Patients with known allergies to medications or materials used during the procedure. 7.Patients with severe mental or neurological impairment who cannot provide informed consent. 8.Patients with uncooperative behaviour or inability to follow pre-procedure instructions (e.g., fasting). 9.Patients with recent myocardial infarction or stroke

Design outcomes

Primary

MeasureTime frame
The diagnostic efficacy in Mini bal done in ICU patient who cannot undergo traditional bronchoscopy and comparing mini bal with traditional bronchoalveolar lavage and endotracheal aspirateTimepoint: 3 days after the procedure

Secondary

MeasureTime frame
Helps in finding the antibiotics sensitivity early and there by reducing the resistance to antibioticsTimepoint: 3 days after the procedure

Countries

India

Contacts

Public ContactRajamani K

Saveetha Medical College

prasanthgd@gmail.com9788852770

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026